Jin Yang Pharmaceutical Co. Ltd (007370) — Capital Reinvestment Ratio
Jin Yang Pharmaceutical Co. Ltd (007370) has a Capital Reinvestment Ratio of 0.04x as of March 2026, meaning it reinvests 0% of its operating cash flow (₩4.53 Billion) in capital expenditures (₩197.80 Million). Check Jin Yang Pharmaceutical Co. Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Jin Yang Pharmaceutical Co. Ltd Capital Reinvestment Ratio (2018–2025)
This chart tracks Jin Yang Pharmaceutical Co. Ltd's Capital Reinvestment Ratio across 8 annual periods. For the full cash flow conversion analysis, see 007370 cash flow metrics.
Annual Capital Reinvestment Ratio for Jin Yang Pharmaceutical Co. Ltd (2018–2025)
Year-by-year Capital Reinvestment Ratio for Jin Yang Pharmaceutical Co. Ltd from 2018 to 2025. See Jin Yang Pharmaceutical Co. Ltd (007370) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 2.51x | ₩1.46 Billion | ₩3.67 Billion | ▲ +3285.2% |
| 2024 | 0.07x | ₩12.79 Billion | ₩947.22 Million | ▼ -58.8% |
| 2023 | 0.18x | ₩8.53 Billion | ₩1.53 Billion | ▼ -58.4% |
| 2022 | 0.43x | ₩7.45 Billion | ₩3.22 Billion | ▼ -66.2% |
| 2021 | 1.28x | ₩1.97 Billion | ₩2.52 Billion | ▲ +485.0% |
| 2020 | 0.22x | ₩6.24 Billion | ₩1.36 Billion | ▲ +113.6% |
| 2019 | 0.10x | ₩7.21 Billion | ₩736.71 Million | ▼ -67.0% |
| 2018 | 0.31x | ₩1.06 Billion | ₩327.39 Million | — |